Triple

T6174821
Position Surface form Disambiguated ID Type / Status
Subject Cancri E137791 entity
Predicate relatedForm P21674 FINISHED
Object Cancer E137795 NE FINISHED

How this triple was built (2 steps)

Every LLM step that produced this triple, in pipeline order — named-entity classification, the disambiguation choices (the exact options shown, with the pick highlighted), and the generated description. The batch + timestamp of each is in the Provenance table below.

NER Named-entity recognition gpt-5-mini
Instruction
Given a phrase, classify it is english named entity (e.g., persons, organizations, works of art) in Latin script, or not (e.g., literals, dates, URLs, verbose phrases). For disambiguation, the statement where the phrase occurs as object is also given. Please return a JSON object with `phrase` (string, the phrase being analyzed) and `is_ne` (boolean, indicating whether the phrase is a Named Entity).
Input
Phrase: Cancer | Statement: [Cancri, relatedForm, Cancer]
NED1 Entity disambiguation (via context triple) gpt-5-mini-2025-08-07
Target entity: Cancer
Context triple: [Cancri, relatedForm, Cancer]
  • A. Cancer chosen
    Cancer is the fourth astrological sign of the zodiac, symbolized by the Crab and traditionally associated with emotional sensitivity, intuition, and nurturing qualities.
  • B. Cancer Research
    Cancer Research is a leading peer-reviewed scientific journal that publishes significant findings in oncology, including basic, translational, and clinical cancer research.
  • C. Cancer Programs
    Cancer Programs is a set of initiatives and standards by the American College of Surgeons focused on improving the quality and outcomes of cancer care across accredited institutions.
  • D. Cancer Discovery
    Cancer Discovery is a leading peer-reviewed scientific journal that publishes cutting-edge research and clinical studies in oncology.
  • E. Division of Cancer Treatment and Diagnosis
    The Division of Cancer Treatment and Diagnosis is a branch of the National Cancer Institute that supports the development, evaluation, and clinical testing of new cancer therapies and diagnostic tools.
  • F. None of above.
  • G. Unsure - the case is ambiguous/there is not enough information to decide.

Provenance (3 batches)

The batch behind each pipeline step, in order, with when it ran. Timestamps are batch-level — stages were processed in waves, so the object chain (NER → NED1 → NEDg → NED2) reads in order, but predicate / elicitation batches can sit in a different wave.

Step Stage Batch ID Status When
creating Elicitation batch_69c008a80f748190ba3d07ffc81acb29 completed March 22, 2026, 3:20 p.m.
NER Named-entity recognition batch_69c05dc55b5c819084482b735771c9a8 completed March 22, 2026, 9:23 p.m.
NED1 Entity disambiguation (via context triple) batch_69c20d7783988190a0f0c8b37abe7069 completed March 24, 2026, 4:05 a.m.
Created at: March 22, 2026, 4:18 p.m.